WallStreetZenWallStreetZen

NASDAQ: MRNA
Moderna Inc Earnings & Revenue

MRNA past earnings growth

How has MRNA's earnings growth performed historically?
Company
67.35%
Industry
19.29%
Market
36.76%
MRNA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
MRNA's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
MRNA's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

MRNA past revenue growth

How has MRNA's revenue growth performed historically?
Company
80.8%
Industry
123.51%
Market
163.96%
MRNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MRNA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MRNA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MRNA earnings and revenue history

Current Revenue
$21.4B
Current Earnings
$11.8B
Current Profit Margin
55%

MRNA Return on Equity

Current Company
70%
Current Industry
-9.8%
Current Market
-8.3%
MRNA's Return on Equity (70%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MRNA announces earnings.

MRNA Return on Assets

Current Company
45.1%
Current Industry
0.6%
MRNA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MRNA Return on Capital Employed

Current Company
69.25%
Current Industry
11.2%
MRNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MRNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MRNA$21.39B$13.68B$11.77B+225.07%+67.35%
VRTX$8.70B$4.23B$3.27B+30.53%+74.11%
REGN$13.71B$6.41B$5.37B+19.97%+33.04%
BNTX$18.20B$14.35B$10.12B+487.71%+17.07%
ALNY$960.92M-$935.29M-$1.18B+69.13%N/A

MRNA earnings dates

Next earnings date
Feb 23, 2023

Moderna Earnings & Revenue FAQ

What were MRNA's earnings last quarter?

On Invalid Date, Moderna (NASDAQ: MRNA) reported Q3 2022 earnings per share (EPS) of $2.67, up 67.71% year over year. Total Moderna earnings for the quarter were $1.04 billion. In the same quarter last year, Moderna's earnings per share (EPS) was $8.27.

If you're new to stock investing, here's how to buy Moderna stock.

What was MRNA's earnings growth in the past year?

As of Q1 2023, Moderna's earnings has grown 67.35% year over year. This is 48.06 percentage points higher than the US Biotechnology industry earnings growth rate of 19.29%. Moderna's earnings in the past year totalled $11.77 billion.

What is MRNA's earnings date?

Moderna's earnings date is Invalid Date. Add MRNA to your watchlist to be reminded of MRNA's next earnings announcement.

What was MRNA's revenue last quarter?

On Invalid Date, Moderna (NASDAQ: MRNA) reported Q3 2022 revenue of $3.36 billion up 32.3% year over year. In the same quarter last year, Moderna's revenue was $4.97 billion.

What was MRNA's revenue growth in the past year?

As of Q1 2023, Moderna's revenue has grown 80.8% year over year. This is 42.72 percentage points lower than the US Biotechnology industry revenue growth rate of 123.51%. Moderna's revenue in the past year totalled $21.39 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.